| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1655675A Combination therapy using trefoil peptides |
| 08/17/2005 | CN1654070A Composite Chinese medicinal soft capsule for treating emmeniopathy and its preparing method |
| 08/17/2005 | CN1654064A Chinese medicinal composition for treating respiratory illness and digestive illness |
| 08/17/2005 | CN1654050A Wind expelling medicinal wine for treating arthritis |
| 08/17/2005 | CN1654046A Chinese drug for treating infantile convulsion, fever, cough and diarrhea due to bird flu virus infection |
| 08/17/2005 | CN1654038A Buccal tablet of tea polyphenol for preventing and treating colds and resisting inflammation and preparation thereof |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same |
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/17/2005 | CN1215052C Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 08/17/2005 | CN1214796C Method for preparing slow release micro pill of aspirin |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6930090 Methods of activating a receptor using amphiphilic drug-oligomer conjugates |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929805 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
| 08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2131350C Sustained release drug formulation containing a tramadol salt |
| 08/11/2005 | WO2005073718A1 Method of screening compound safe to gastric mucosa |
| 08/11/2005 | WO2005041858A3 Mucin production inhibitor |
| 08/11/2005 | WO2004112837A8 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR |
| 08/11/2005 | WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof |
| 08/11/2005 | US20050177876 Fcyriia transgenic animal model for autoimmune disease |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176825 a mixture of quinic acid and salts, and nontoxic inert carriers or diluents; solvent extraction |
| 08/11/2005 | US20050176824 Novel substance having antitumor/anti-inflammatory activity |
| 08/11/2005 | US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176814 mono- or polydeuterated 4-(p-Methylsulfonylphenyl]-3-phenyl-2-(5H)-furanones; degenerative joint disorders, acute pain and primary dysmenorrhea |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176803 Indole derivatives as anti-inflammatory agents |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176775 Substituted pyridinones |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176753 controlling signal transduction; anticancer agents; antitumor agnets; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 08/11/2005 | US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176715 Piperidine derivatives |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176672 Use of cationic lipids to generate anti-tumor immunity |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus |
| 08/11/2005 | US20050176631 Method for reducing morbidity and mortality in critically ill patients |
| 08/11/2005 | US20050176060 Crystal structure |
| 08/11/2005 | US20050176004 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 08/11/2005 | US20050175699 Multilamellar system for the administration of active agents by means of ingestion |
| 08/11/2005 | US20050175639 Methods |
| 08/11/2005 | US20050175555 2,4,6,8,10,12,14-hexadecaheptaenol in cyclodextrins; antitumor , antiinflammatory, antiaging, antiprolifrative agent, antioxident; activation of free radical production, cardiovascular disorders, atherosclerosis; cosmetic and pharmaceutical use |
| 08/11/2005 | CA2554886A1 Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 08/11/2005 | CA2554749A1 P2x receptor inhibitor |
| 08/11/2005 | CA2554735A1 Therapeutic and carrier molecules |
| 08/11/2005 | CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 08/10/2005 | EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases |
| 08/10/2005 | EP1560834A1 New tricyclic derivatives as ltd4 antagonists |
| 08/10/2005 | EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 08/10/2005 | EP1560823A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560582A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 08/10/2005 | EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 08/10/2005 | EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 08/10/2005 | EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/10/2005 | EP1358187B1 Naphthyridine derivatives |
| 08/10/2005 | EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1324760A4 Creatine ester pronutrient compounds and formulations |
| 08/10/2005 | EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | EP1194425B1 Substituted benzimidazole |
| 08/10/2005 | EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 08/10/2005 | CN1653182A Recombinant fowlpox virus |
| 08/10/2005 | CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/10/2005 | CN1653050A Opioid and opioid-like compounds and uses thereof |
| 08/10/2005 | CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents |
| 08/10/2005 | CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 08/10/2005 | CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |